Most Read
Most Commented
mk-logo
News
BioNTech to price vaccine below market rates, differentiate between regions

BioNTech, first in the race to produce evidence of a working Covid-19 vaccine, is planning to price the two-shot regimen below "typical market rates" and would differentiate pricing between countries or regions.

Speaking at a Financial Times online event, the German biotech firm's strategy head Ryan Richardson said the price tag of the vaccine, which is co-developed with Pfizer and which has yet to win regulatory approval, would reflect the financial risks that its private-sector investors have incurred...

Unlocking Article
Unlocking Article
View Comments
ADS